Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30027118HIVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20007304HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20007305HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20007306HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20013263HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20021893HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TCGA Plot Options
Drug Information
GeneAKR1C3
DrugBank IDDB09074
Drug NameOlaparib
Target IDBE0000592
UniProt IDP42330
Regulation Typeinhibitor
PubMed IDs33114555
CitationsTavares TS, Hofman J, Lekesova A, Zelazkova J, Wsol V: Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3. Cancers (Basel). 2020 Oct 26;12(11). pii: cancers12113127. doi: 10.3390/cancers12113127.
GroupsApproved
Direct ClassificationPhthalazinones
SMILESFC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
Pathways
PharmGKB
ChEMBLCHEMBL521686